Product category:
Chemicals and biochemicals
News Release from: Invitrogen | Subject: FreeStyle Max
Edited by the Laboratorytalk Editorial
Team on 20 October 2006
System for large scale protein
production
Invitrogen has introduced the FreeStyle Max system - designed for large scale protein production in the preferred cell lines for a number of bio-pharmaceutical and pre-clinical applications
Invitrogen's FreeStyle Max system enables wide range of bio-pharmaceutical and pre-clinical applications "Our first try with the new system gave over ten-fold higher yields of the same recombinant protein from the same vectors," said David Wilson, vice-president, therapeutic antibody development at Evogenix, one of the early evaluators of the FreeStyle Max system
This article was originally published on Laboratorytalk on 14 Sep 2005 at 8.00am (UK)
Related stories
Profiling service for immune response biomarkers
Provides researchers with a discovery method for rapid identification of biomarkers specific to disease states that result from altered immunoreactivity to self proteins
Cell lines keep on growing
Rapidly and reliably determine the intracellular status of key signal transduction pathways upon exposure to drug candidates or other stimuli
The FreeStyle Max System is a protein production technology developed for rapid, large-scale generation of post-translationally modified, functional proteins in Chinese hamster ovary (CHO) and HEK-293 suspension cell cultures.
It is the first commercially available large-scale transient transfection system optimized with CHO suspension culture - the preferred cell line for pre-clinical testing and producing FDA-approved protein for therapeutic applications.
Using suspension cultures and transient transfection methods, researchers are now able to generate significantly higher levels of protein in the preferred cell lines for these applications in days compared to months required for generating stable cell lines.
"We listened to our customers and matched our product development focus to their requirements for protein production in their applications," concluded Mark Gardner, Invitrogen's vice president of molecular biology essentials.
"With the introduction of FreeStyle Max, we have delivered a new system of technologies to meet these needs.".
• Invitrogen: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

